APA (7th ed.) Citation

Hu, X., Zhang, S., Ma, Z., Feng, J., Wu, L., Lv, D., . . . Zhao, H. (2023). Central nervous system efficacy of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small cell lung cancer: A pooled analysis from two phase 2 studies. BMC Medicine, 21(1), 1. https://doi.org/10.1186/s12916-023-02865-z

Chicago Style (17th ed.) Citation

Hu, Xingsheng, et al. "Central Nervous System Efficacy of Furmonertinib (AST2818) in Patients with EGFR T790M Mutated Non-small Cell Lung Cancer: A Pooled Analysis from Two Phase 2 Studies." BMC Medicine 21, no. 1 (2023): 1. https://doi.org/10.1186/s12916-023-02865-z.

MLA (9th ed.) Citation

Hu, Xingsheng, et al. "Central Nervous System Efficacy of Furmonertinib (AST2818) in Patients with EGFR T790M Mutated Non-small Cell Lung Cancer: A Pooled Analysis from Two Phase 2 Studies." BMC Medicine, vol. 21, no. 1, 2023, p. 1, https://doi.org/10.1186/s12916-023-02865-z.